glucose brands
86 registered brands containing glucose in Kenya.
Glucose
PubChem CID 5793Molecular formula: C6H12O6
Glucose supplies most of the energy to all tissues by generating energy molecules ATP and NADH during a series of metabolism reactions called glycolysis. Glycolysis can be divided into two main phases where the preparatory phase is initiated by the phosphorylation of glucose by hexokinase to form glucose 6-phosphate. The addition of the high-energy phosphate group activates glucose for the subsequent breakdown in later steps of glycolysis and is the rate-limiting step. Products end up as substrates for following reactions, to ultimately convert C6 glucose molecule into two C3 sugar molecules. These products enter the energy-releasing phase where the total of 4ATP and 2NADH molecules are generated per one glucose molecule. The total aerobic metabolism of glucose can produce up to 36 ATP molecules. These energy-producing reactions of glucose are limited to D-glucose as L-glucose cannot be phosphorylated by hexokinase. Glucose can act as precursors to generate other biomolecules such as vitamin C. It plays a role as a signaling molecule to control glucose and energy homeostasis. Glucose can regulate gene transcription, enzyme activity, hormone secretion, and the activity of glucoregulatory neurons. The types, number, and kinetics of glucose transporters expressed depends on the tissues and fine-tunes glucose uptake, metabolism, and signal generation to preserve cellular and whole body metabolic integrity. Vascular calcification is a hallmark of type 2 diabetes. Glucose stimulates calcification in culture of vascular smooth muscle cells (VSMCs) but the underlying mechanisms remain obscure. We observed that high glucose levels stimulated mouse and human VSMC trans-differentiation into chondrocytes, with increased levels of Sox9, type II collagen, glycosaminoglycan and Runx2 expression, and increased alkaline phosphatase activity and mineralization. These effects were associated with increased expression of IL-1beta, which stimulated alkaline phosphatase and calcification, suggesting that glucose induces chondrocyte differentiation of VSMCs, possibly through IL-1beta activation.
Source: PubChem (NCBI) ยท compound 5793
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| 10-D IV INFUSION 10% |
Nairobi Pharmaceuticals | Registered | Kenya |
| 10D 100G/L |
Reddys Pharma | Registered | Kenya |
| 10D IV INFUSION GLUCOSE 10% W/V |
Aiveen | Registered | Kenya |
| 5D 50 G/L |
Reddys Pharma | Registered | Kenya |
| AXADEX D5 SOLUTION FOR INFUSION(500ML) GLUCOSE ANHYDROUS BP 5% W/V PER ML |
Evka Consultz | Registered | Kenya |
| D10 10.0% |
Abacus Pharma | Registered | Kenya |
| D10 STERILIFE ANHYDROUS GLUCOSE BP 10.0% W/V |
Crown Healthcare | Registered | Kenya |
| D5 5.0% W/V ANHYDROUS GLUCOSE |
Abacus Pharma | Registered | Kenya |
| D5 Infusion |
Abacus Pharma Ltd | Retained | Kenya |
| D5 Infusion |
Abacus Pharma Ltd | Retained | Kenya |
| D5 INTRAVENOUS INFUSION 500ML 50GM/L |
Surgilinks | Registered | Kenya |
| D50 GLUCOSE INTRAVENOUS 50%W/V |
Abacus Pharma | Registered | Kenya |
| DAWALYTE PREPARED SOLUTION CONTAINS:SODIUM IONS 75MMOL/L, POTASSIUM IONS 20MMOL/L, CHLORIDE IONS 65MMOL/L, CITRATE IONS 10MMOL/L AND GLUCOSE 75MMOL/L |
Dawa | Registered | Kenya |
| DEHYDRATION TREATMENT SALTS (DTS) EACH 10.30G SACHET CONTAINS: 1.30G:0.75G:1.45G:6.75G AND EACH 20.60G SACHET CONTAINS: 2.60G:1.50G:2.90G:13.50G |
Cosmos | Registered | Kenya |
| DEX 10 100MG/ML |
United Pharma | Registered | Kenya |
| DEX&NS 0.9G & 5G |
United Pharma | Registered | Kenya |
| DEX-10% 10% |
Pro Med Pharmaceuticals | Registered | Kenya |
| DEX-5% 5% |
Pro Med Pharmaceuticals | Registered | Kenya |
| DEX-5% 5G |
United Pharma | Registered | Kenya |
| DEXATAS 10% SOLUTION FOR INFUSION 10% |
Tasa Pharma | Registered | Kenya |
| DEXATAS 25% SOLUTION FOR INFUSION 25% |
Tasa Pharma | Registered | Kenya |
| DEXATAS 5% SOLUTION FOR INFUSION 5% |
Tasa Pharma | Registered | Kenya |
| DEXATAS 50 % CONCENTRATE FOR SOLUTION FOR INFUSION 50% |
Tasa Pharma | Registered | Kenya |
| DEXTROSE IV 5% 5%W/V |
Pro Med Pharmaceuticals | Registered | Kenya |
| DEXTROSE IV 50% 50%W/V |
Pro Med Pharmaceuticals | Registered | Kenya |
| DIAGONEKIT 1. EACH TABLET CONTAINS: ZINC SULFATE MONOHYDRATE USP 54.89MG EQUIVALENT TO 20MG ZINC. 2. ORS: EACH 10.30G CONTAINS: GLUCOSE ANHYDROUS BP 6.75G, SODIUM CHLORIDE BP 1.30G, TRISODIUM CITRATE DIHYDRATE BP 1.45G AND POTASSIUM CHLORIDE BP 0.75G |
Laboratory & Allied | Registered | Kenya |
| DIORS 500 ML EACH SATCHET (10.3 G) CONTAINS GLUCOSE BP (ANHYDROUS) 6.75 G SODIUM CITRATE BP 1.45 G SODIUM CHLORIDE BP 1.30 G POTASSIUM CHLORIDE BP 0.75 G |
Dinlas Pharma | Registered | Kenya |
| DNS SODIUM CHLORIDE BP 0.9 %W/V, ANHYDROUS GLUCOSE 5.0% W/V |
Goodmed Healthcare | Registered | Kenya |
| DNS 5.0%W/V ANHYDROUS GLUCOSE AND 0.9%W/V SODIUM CHLORIDE |
Abacus Pharma | Registered | Kenya |
| DNS Solution For Infusion |
Abacus Pharma Ltd | Retained | Kenya |
| DNS STERILIFE SODIUM CHLORIDE BP 0.9 %W/V ANHYDROUS GLUCOSE 5.0% W/V |
Crown Healthcare | Registered | Kenya |
| DTS-Z KIT EACH 10.30G SACHET (DTS) CONTAINS: 1.30G, 0.75G, 1.45, 6.75G AND EACH TABLET (ZINCOS) CONTAINS: ZINC SULFATE MONOHYDRATE USP (54.89MG) EQUIVALENT TO 20MG ELEMENTAL ZINC |
Cosmos | Registered | Kenya |
| ELECTRAL (ORAL REHYDRATION SALTS BP) 21.8GMS EACH 21.8 G SACHET CONTAINS: SODIUM CHLORIDE BP 2.60 G, POTASSIUM CHLORIDE BP 1.50 G, SODIUM CITRATE BP 2.90 G, ANHYDROUS GLUCOSE BP 13.50G |
Surgipharm | Registered | Kenya |
| ELECTRORUSH ORS POWDER XXXXX SODIUM CHLORIDE BP 2.60G, POTTASIUM CHLORIDE BP 1.50G, SODIUM CITRATE BP 2.90 G, GLUCOSE ANHYDROUS BP 13.50 G . |
Syner-med Pharmaceuticalsltd | Registered | Kenya |
| ELECTRORUSH POWDER SODIUM CHLORIDE BP 2.60GM; POTASSIUM CHLORIDE BP 1.50GM; SODIUM CITRATE BP 2.90GM; GLUCOSE ANHYDROUS BP 13.50GM |
Syner-med Pharmaceuticalsltd | Registered | Kenya |
| GLUCOSE INJECTION 5%, 500ML 500ML: 25G |
Nairobi Enterprises | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSION BP (5% W/V EACH 100 ML CONTAINS GLUCOSE (AS ANHYDROUS) B.P 5.0 GM |
Nairobi Pharmaceuticals | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSION BP (5% W/V) GLUCOSE INTRAVENOUS INFUSION BP 5% W/V |
Knvm Medicare | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSION BP (50% W/V) EACH VIAL CONTAINS GLUCOSE AS ANHYDROUS BP 50.0GM |
Nairobi Pharmaceuticals | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSION BP (D5) 5%W/V 5%W/V |
Shalina Healthcare | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSION BP 10%W/V 100MG/ML |
Dawa | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSION BP 5%W/V 50MG/ML |
Dawa | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSION BP 50 G/L EACH ML CONTAINS: ANHYDROUS GLUCOSE BP 50 MG |
Highchem | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSION BP 50% W/V GLUCOSE ANHYDROUS 50% |
Surgilinks | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSIONS 10%W/V |
B Braun Pharmaceuticals | Registered | Kenya |
| GLUCOSE INTRAVENOUS INFUSIONS 5% |
B Braun Pharmaceuticals | Registered | Kenya |
| GLUCOSE IV INFUSION 0.5%W/V |
Reddys Pharma | Registered | Kenya |
| GLUCOSE IV INFUSION GLUCOSE BP 5G PER 100ML |
Aiveen | Registered | Kenya |
| GLUCOSE IV INFUSION BP (5% W/V) GLUCOSE IV INFUSION BP 5%W/V |
Surgilinks | Registered | Kenya |
| KABIVEN 1000 ML CONTAINS: 107 G (CORRESP. TO) (97G) 39G 4.7G 3.3G 0.99G 1.6G 2.3G 2G 1.6G 2.3G 3.3G (CORRESP.) TO (2.6G) 1.6G 2.3G 2G 1.3G 1.6G 0.56G 0.07G 2.1G 0.29G (CORRESP.) TO (0.22G) 0.96G (CORRESP. TO (0.47G) |
Surgipharm | - | Kenya |